Castleview Partners »

Cardiff Oncology shares owned by Castleview Partners

Quarter-by-quarter ownership of Cardiff Oncology (CRDF) shares owned by Castleview Partners from 13F filings

Historical chart of Castleview Partners investment in Cardiff Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cardiff Oncology held by Castleview Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cardiff Oncology by Castleview Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $44k 14k 3.15
2025-03-31 $45k 15k 3.14

More positions owned by Castleview Partners

Valued Advisers Tr Regan Fltg Rate (MBSF)
Apple (AAPL)
Advisor Managed Portfolios Regan Fixed Rate (MBSX)
ConocoPhillips (COP)
Home Depot (HD)
Managed Portfolio Series Leuthold Select (LST)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
Advisors Inner Circle Fd Ii Pmv Adaptive Rsk (ARP)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Bristol Myers Squibb (BMY)
Amgen (AMGN)
Fidelity Covington Trust High Divid Etf (FDVV)
Proshares Tr Pshs Ultra Qqq (QLD)
Vaneck Merk Gold Etf Gold Shs (OUNZ)

View all positions for Castleview Partners

Top funds holding Cardiff Oncology

BlackRock
Vanguard Group
Laurion Capital Management
Pfizer
William Blair $ Company
Acorn Capital Advisors
Geode Capital Management
State Street Corporation
UBS Group
Putnam Fl Investment Management
Northern Trust
Goldman Sachs Group
Bank of New York Mellon
Susquehanna International
Citadel Advisors

View all funds holding Cardiff Oncology